Press Releases

Filter Releases
 
Press Releases
Date Title and Summary View
Jan 4, 2011 WALTHAM, Mass., Jan 04, 2011 (BUSINESS WIRE) --NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it will shift its business focus to diabetes, specifically detection and monitoring of diabetic neuropathy which is a common complication of the disease. The Company will continue to support its neurodiagnostic busi...
Jan 26, 2011 WALTHAM, Mass., Jan 26, 2011 (BUSINESS WIRE) --NeuroMetrix, Inc. (Nasdaq: NURO) today said it plans to issue its 2010 fourth quarter financial results before the opening of the market on February 3, 2011. The Company will host a conference call at 8:00 am eastern time on February 3, 2010 to discuss its fourth quart...
Feb 3, 2011 WALTHAM, Mass., Feb 03, 2011 (BUSINESS WIRE) --NeuroMetrix, Inc. (Nasdaq: NURO), a science-based health care company transforming patient care through neurotechnology, today reported business and financial highlights for the quarter and year ended December 31, 2010. On January 4, 2011, NeuroMetri...
Feb 9, 2011 WALTHAM, Mass., Feb 09, 2011 (BUSINESS WIRE) --NeuroMetrix, Inc. (Nasdaq: NURO), a health care company transforming patient care through neurotechnology, today announced that Shai N. Gozani M.D., Ph.D., President and Chief Executive Officer, will be presenting at the Canaccord Genuity Musculoskeletal Conference at ...
Mar 21, 2011 WALTHAM, Mass., Mar 21, 2011 (BUSINESS WIRE) --NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it has formed a scientific advisory board of international experts to help guide the scientific, clinical and market development of its diabetic peripheral neuropathy (DPN) test. The device is a modified version of ...
Apr 13, 2011 WALTHAM, Mass., Apr 13, 2011 (BUSINESS WIRE) --NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it will preview its newest product - NC-stat® | DPNCheck™ - at the Annual Meeting of the American Association of Clinical Endocrinologi...
Apr 21, 2011 WALTHAM, Mass., Apr 21, 2011 (BUSINESS WIRE) --NeuroMetrix, Inc. (Nasdaq: NURO) today said it plans to issue its 2011 first quarter financial results before the opening of the market on April 28, 2011. The Company will host a conference call at 8:00 am eastern time on April 28, 2011 to discuss its first quarter fin...
Apr 28, 2011 WALTHAM, Mass., Apr 28, 2011 (BUSINESS WIRE) --NeuroMetrix, Inc. (Nasdaq: NURO), a science-based health care company transforming patient care through neurotechnology, today reported business and financial highlights for the quarter ended March 31, 2011. NeuroMetrix has focused its business strategy on t...
Jun 1, 2011 WALTHAM, Mass., Jun 01, 2011 (BUSINESS WIRE) --NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it will exhibit at the annual meeting of The Endocrine Society in Boston on June 4-6, 2011. The exhibition will include a demonstration of its newest product - NC-stat®...
Jun 15, 2011 WALTHAM, Mass. & FT LAUDERDALE, Fla., Jun 15, 2011 (BUSINESS WIRE) --Nipro Diagnostics, Inc. and NeuroMetrix, Inc. (Nasdaq: NURO) today announced their collaboration to evaluate opportunities for NC-stat® | DPNCheck™ in retail medic...
Jun 20, 2011 WALTHAM, Mass., Jun 20, 2011 (BUSINESS WIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it expects to meet its planned launch date for its latest product, NC-stat®|DPNCheck™, which is a fast, accurate, and quantitative test for the evaluation of sy...
Jul 6, 2011 WALTHAM, Mass., Jul 06, 2011 (BUSINESS WIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it met its planned marketing launch date for NC-stat®|DPNCheck™, which is a fast, accurate, and quantitative test for the evaluation of systemic neu...
Jul 21, 2011 WALTHAM, Mass., Jul 21, 2011 (BUSINESS WIRE) --NeuroMetrix, Inc. (Nasdaq: NURO) today said it plans to issue its 2011 second quarter financial results before the opening of the market on July 28, 2011. The Company will host a conference call at 8:00 a.m., Eastern time on July 28, 2011 to discuss its second quarter ...
Jul 28, 2011 WALTHAM, Mass., Jul 28, 2011 (BUSINESS WIRE) --NeuroMetrix, Inc. (Nasdaq: NURO), a science-based health care company improving patient care through neurotechnology, today reported business and financial highlights for the quarter and six months ended June 30, 2011. NeuroMetrix is focused on apply...
Aug 2, 2011 WALTHAM, Mass., Aug 02, 2011 (BUSINESS WIRE) --NeuroMetrix, Inc. (Nasdaq: NURO), a science-based health care company improving patient care through neurotechnology, today announced that Shai N. Gozani M.D., Ph.D., President and Chief Executive Officer, is scheduled to speak at the Canaccord Genuity Growth Conferenc...
Page:
2
...
20
Next Last
 
= add release to Briefcase